30
Apr, 2025
Business Exhibition
Ta Fong Participates in CPHI Japan 2025 to Expand Partnership Opportunities in Japan
Ta Fong Pharmaceutical participated in CPHI Japan 2025 at Tokyo Big Sight, one of Asia’s leading pharmaceutical industry exhibitions. As part of the Taiwan Pharmaceutical Alliance (TPA) pavilion, Ta Fong joined other leading Taiwanese pharmaceutical manufacturers to demonstrate the strength and competitiveness of Taiwan’s pharmaceutical industry on the international stage.
During the exhibition, Ta Fong highlighted its manufacturing capabilities across sterile products, solid dosage forms, and topical formulations. The event provided valuable opportunities to engage with pharmaceutical professionals from Japan and other international markets, exchanging insights and exploring potential collaborations in contract manufacturing, product supply, and business development.
Through participation in CPHI Japan, Ta Fong further strengthened relationships with global partners while gaining deeper insights into market demands and industry trends in Japan. Moving forward, the company remains committed to enhancing its product portfolio and service offerings, expanding its international presence, and building long-term partnerships that support sustainable global growth.
